Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet-Fed Mice. Diabetes 2009;58:2910-2919. DOI: 10.2337/db08-0506. PMID: 19696185. (Q41059950)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet-Fed Mice. Diabetes 2009;58:2910-2919. DOI: 10.2337/db08-0506. PMID: 19696185. |
scientific article |
Statements
Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet-Fed Mice. Diabetes 2009;58:2910-2919. DOI: 10.2337/db08-0506. PMID: 19696185. (English)
1 reference
Lício A Velloso
1 reference
Roberto Rittner
1 reference
Kleber G Franchini
1 reference
Patricia O Prada
1 reference
Eduardo R Ropelle
1 reference
Rosa H Mourão
1 reference
Claudio T de Souza
1 reference
Jose R Pauli
1 reference
Dennys E Cintra
1 reference
André Schenka
1 reference
Silvana A Rocco
1 reference
José Vassallo
1 reference
José B Carvalheira
1 reference
Mario J A Saad
1 reference
27 April 2017
1 reference
1 reference
66
1 reference
7
1 reference
2059
1 reference
Identifiers
1 reference
1 reference
1 reference